Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1287729
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1287729
Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global dermatology drugs market size is expected to reach USD 50.47 billion by 2032, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The dermatology drugs market is experiencing a surge in demand due to a growing burden of dermatology diseases globally, with increasing prevalence rates. Increased awareness of disease progression and etiology has increased, leading to a higher demand for effective treatments. The rise in the elderly population has contributed significantly to the market's growth.
Older individuals are more susceptible to skin-related disorders due to various physiological changes associated with aging. For instance, changes in the connective tissue, reduction in skin strength and elasticity, and decrease in sebaceous gland secretions are common in aging individuals, leading to a higher demand for dermatology drugs.
Dermatology is a diverse specialty encompassing disorders and diseases of the skin, mucous membrane, hair, and nails. Conditions in this category include acne, multiple inflammatory dermatoses, skin cancers, autoimmune disease, occupational dermatitis, and contact dermatitis. It's a highly fragmented therapeutic area, under which comes acne, rosacea, psoriasis, atopic dermatitis, and other disorders.
Biologics are becoming a popular treatment option for dermatological conditions due to their effectiveness and targeted approach, with many drugs approved by regulatory bodies and more in development. Patients also increasingly prefer topical treatments over systemic medications due to convenience, fewer side effects, and targeted approach, leading to a rise in the demand for topical dermatology drugs. The rising demand in emerging markets, increasing adoption of combination therapies, and focus on personalized medicine are also driving growth in the industry.
For instance, In March 2022, Johnson & Johnson's Janssen Pharmaceutical Companies initiated a prospective clinical trial named VISIBLE to evaluate the safety and efficacy of a drug for people of color suffering from moderate to severe plaque and/or scalp psoriasis.
Dermatology Drugs Market Report Highlights
- Psoriasis segment is accounted for the largest market share because of the increasing the prevalence of psoriasis globally and manufacturers launching new medications for the treatment.
- Corticosteroids segment holds the highest CAGR of the market. in various conditions of skin disorders topical corticosteroids are used widely in conditions such as psoriasis, dermatitis, acne and others.
- parenteral segment holds the largest share in the market, due to various biologics are available for the dermatological conditions, and biologics are generally taken through the parenteral route of administration.
- Hospital pharmacy segment dominated the market and willing to continue its dominance over the forecast period. Nowadays peoples are aware with the skin diseases that's why increased in the patient visits to hospitals and sales of prescription drugs increased.
- North America holds the largest market share in the market and expected to maintain its dominance during the forecast period. Increased in the awareness of skin diseases and raising the treatment and key players making the developments in this market fuels the growth of the region.
- The global key market players include: Lupin, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi, Amgen Inc., Lilly, AstraZeneca, AbbVie Inc., Johnson & Johnson Private Limited, LEO Pharma A/S, Merck & Co. Inc., Bausch Health Companies Inc., and Bristol-Myers Squibb Company.
Polaris Market Research has segmented the dermatology drugs market report based on therapeutic area, drug class, route of administration, distribution channel, and region:
Dermatology Drugs, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)
- Acne
- Atopic Dermatitis
- Psoriasis
- Rosacea
- Others
Dermatology Drugs, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)
- Anti-infectives
- Corticosteroids
- Anti-acne
- Calcineurin Inhibitors
- Retinoids
- Others
Dermatology Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Topical
- Oral
- Parenteral
Dermatology Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Dermatology Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM1106
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Dermatology Drugs Market Insights
- 4.1. Dermatology Drugs - Industry Snapshot
- 4.2. Dermatology Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Elderly Population
- 4.2.1.2. Rise in Clinical Studies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Dermatology Drugs Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Dermatology Drugs Market, by Therapeutic Area
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 5.3. Acne
- 5.3.1. Global Dermatology Drugs Market, by Acne, by Region, 2019-2032 (USD Billion)
- 5.4. Atopic Dermatitis
- 5.4.1. Global Dermatology Drugs Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
- 5.5. Psoriasis
- 5.5.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2019-2032 (USD Billion)
- 5.6. Rosacea
- 5.6.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Dermatology Drugs Market, by Drug Class
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 6.3. Anti-infectives
- 6.3.1. Global Dermatology Drugs Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
- 6.4. Corticosteroids
- 6.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
- 6.5. Anti-acne
- 6.5.1. Global Dermatology Drugs Market, by Anti-acne, by Region, 2019-2032 (USD Billion)
- 6.6. Calcineurin Inhibitors
- 6.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
- 6.7. Retinoids
- 6.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2019-2032 (USD Billion)
- 6.8. Others
- 6.8.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Dermatology Drugs Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 7.3. Topical
- 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
- 7.4. Oral
- 7.4.1. Global Dermatology Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
- 7.5. Parenteral
- 7.5.1. Global Dermatology Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)
8. Global Dermatology Drugs Market, by Distribution Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3. Hospital Pharmacy
- 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
- 8.4. Retail Pharmacy
- 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
- 8.5. Online Pharmacy
- 8.5.1. Global Dermatology Drugs Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)
9. Global Dermatology Drugs Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Dermatology Drugs Market - North America
- 9.3.1. North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.3.2. North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.3. North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.3.4. North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.5. Dermatology Drugs Market - U.S.
- 9.3.5.1. U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.6. Dermatology Drugs Market - Canada
- 9.3.6.1. Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4. Dermatology Drugs Market - Europe
- 9.4.1. Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.2. Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.3. Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.4. Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.5. Dermatology Drugs Market - UK
- 9.4.5.1. UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.6. Dermatology Drugs Market - France
- 9.4.6.1. France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.6.2. France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.6.3. France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.6.4. France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.7. Dermatology Drugs Market - Germany
- 9.4.7.1. Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.8. Dermatology Drugs Market - Italy
- 9.4.8.1. Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.9. Dermatology Drugs Market - Spain
- 9.4.9.1. Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.10. Dermatology Drugs Market - Netherlands
- 9.4.10.1. Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.11. Dermatology Drugs Market - Russia
- 9.4.11.1. Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5. Dermatology Drugs Market - Asia Pacific
- 9.5.1. Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.5. Dermatology Drugs Market - China
- 9.5.5.1. China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.5.3. China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.5.4. China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.6. Dermatology Drugs Market - India
- 9.5.6.1. India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.6.3. India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.6.4. India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.7. Dermatology Drugs Market - Japan
- 9.5.7.1. Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.8. Dermatology Drugs Market - Malaysia
- 9.5.8.1. Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.9. Dermatology Drugs Market - Indonesia
- 9.5.9.1. Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.10. Dermatology Drugs Market - South Korea
- 9.5.10.1. South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6. Dermatology Drugs Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.5. Dermatology Drugs Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.6. Dermatology Drugs Market - South Africa
- 9.6.6.1. South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.7. Dermatology Drugs Market - Israel
- 9.6.7.1. Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.8. Dermatology Drugs Market - UAE
- 9.6.8.1. UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7. Dermatology Drugs Market - Latin America
- 9.7.1. Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.5. Dermatology Drugs Market - Mexico
- 9.7.5.1. Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.6. Dermatology Drugs Market - Brazil
- 9.7.6.1. Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.7. Dermatology Drugs Market - Argentina
- 9.7.7.1. Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Lupin
- 11.1.1. Company Overview
- 11.1.2. Financial PerRoute of Administrationance
- 11.1.3. Distribution Channel Benchmarking
- 11.1.4. Recent Development
- 11.2. Novartis AG
- 11.2.1. Company Overview
- 11.2.2. Financial PerRoute of Administrationance
- 11.2.3. Distribution Channel Benchmarking
- 11.2.4. Recent Development
- 11.3. F. Hoffmann-La Roche Ltd
- 11.3.1. Company Overview
- 11.3.2. Financial PerRoute of Administrationance
- 11.3.3. Distribution Channel Benchmarking
- 11.3.4. Recent Development
- 11.4. Pfizer Inc
- 11.4.1. Company Overview
- 11.4.2. Financial PerRoute of Administrationance
- 11.4.3. Distribution Channel Benchmarking
- 11.4.4. Recent Development
- 11.5. Sanofi
- 11.5.1. Company Overview
- 11.5.2. Financial PerRoute of Administrationance
- 11.5.3. Distribution Channel Benchmarking
- 11.5.4. Recent Development
- 11.6. Amgen Inc
- 11.6.1. Company Overview
- 11.6.2. Financial PerRoute of Administrationance
- 11.6.3. Distribution Channel Benchmarking
- 11.6.4. Recent Development
- 11.7. Lilly
- 11.7.1. Company Overview
- 11.7.2. Financial PerRoute of Administrationance
- 11.7.3. Distribution Channel Benchmarking
- 11.7.4. Recent Development
- 11.8. AstraZeneca
- 11.8.1. Company Overview
- 11.8.2. Financial PerRoute of Administrationance
- 11.8.3. Distribution Channel Benchmarking
- 11.8.4. Recent Development
- 11.9. AbbVie Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial PerRoute of Administrationance
- 11.9.3. Distribution Channel Benchmarking
- 11.9.4. Recent Development
- 11.10. Johnson & Johnson Private Limited
- 11.10.1. Company Overview
- 11.10.2. Financial PerRoute of Administrationance
- 11.10.3. Distribution Channel Benchmarking
- 11.10.4. Recent Development
- 11.11. LEO Pharma A/S
- 11.11.1. Company Overview
- 11.11.2. Financial PerRoute of Administrationance
- 11.11.3. Distribution Channel Benchmarking
- 11.11.4. Recent Development
- 11.12. Merck & Co. Inc
- 11.12.1. Company Overview
- 11.12.2. Financial PerRoute of Administrationance
- 11.12.3. Distribution Channel Benchmarking
- 11.12.4. Recent Development
- 11.13. Bausch Health Companies Inc
- 11.13.1. Company Overview
- 11.13.2. Financial PerRoute of Administrationance
- 11.13.3. Distribution Channel Benchmarking
- 11.13.4. Recent Development
- 11.14. Bristol-Myers Squibb Company
- 11.14.1. Company Overview
- 11.14.2. Financial PerRoute of Administrationance
- 11.14.3. Distribution Channel Benchmarking
- 11.14.4. Recent Development
Product Code: PM1106
List of Tables
- Table 1 Global Dermatology Drugs Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
- Table 2 Global Dermatology Drugs Market, by Drug Class, by Region, 2019-2032 (USD Billion)
- Table 3 Global Dermatology Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
- Table 4 Global Dermatology Drugs Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
- Table 5 Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 6 North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 7 North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 10 U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 11 U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 12 U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 13 U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 14 Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 15 Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 16 Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 17 Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 18 Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 19 Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 20 Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 21 Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 22 Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 23 Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 24 Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 25 Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 26 France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 27 France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 28 France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 29 France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 30 UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 31 UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 32 UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 33 UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 34 Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 35 Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 36 Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 37 Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 38 Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 39 Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 40 Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 41 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 42 Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 43 Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 44 Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 45 Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 46 Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 47 Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 48 Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 49 Russia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 50 Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 51 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 52 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 53 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 54 China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 55 China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 56 China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 57 China: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 58 Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 59 Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 60 Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 61 Japan: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 62 India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 63 India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 64 India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 65 India: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 66 Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 67 Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 68 Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 69 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 70 Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 71 Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 72 Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 73 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 74 South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 75 South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 76 South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 77 South Korea: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 78 Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 79 Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 80 Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 81 Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 82 Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 83 Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 84 Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 85 Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 86 Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 87 Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 88 Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 89 Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 90 Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 91 Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 92 Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 93 Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 94 Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 95 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 96 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 97 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 98 UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 99 UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 100 UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 101 UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 102 Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 103 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 104 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 105 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 106 South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 107 South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 108 South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 109 South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 110 Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
- Table 111 Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
- Table 112 Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 113 Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Dermatology Drugs Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Therapeutic Area
- Figure 7. Global Dermatology Drugs Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
- Figure 8. Market by Distribution Channel
- Figure 9. Global Dermatology Drugs Market, by Distribution Channel, 2021 & 2030 (USD Billion)
- Figure 10. Market by Drug Class
- Figure 11. Global Dermatology Drugs Market, by Drug Class, 2021 & 2030 (USD Billion)
- Figure 12. Market by Route of Administration
- Figure 13. Global Dermatology Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.